Trial Profile
A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Nov 2008
Price :
$35
*
At a glance
- Drugs Pitrakinra (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- 25 Nov 2008 New trial record.